CN108126062A - A kind of oral Chinese medicine composition for treating depression and its preparation and preparation method - Google Patents

A kind of oral Chinese medicine composition for treating depression and its preparation and preparation method Download PDF

Info

Publication number
CN108126062A
CN108126062A CN201810196624.3A CN201810196624A CN108126062A CN 108126062 A CN108126062 A CN 108126062A CN 201810196624 A CN201810196624 A CN 201810196624A CN 108126062 A CN108126062 A CN 108126062A
Authority
CN
China
Prior art keywords
weight
parts
radix
manjusri
orchid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810196624.3A
Other languages
Chinese (zh)
Other versions
CN108126062B (en
Inventor
杨添淞
孙维伯
聂宏
许骏
杨燕
王德龙
李超然
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810196624.3A priority Critical patent/CN108126062B/en
Publication of CN108126062A publication Critical patent/CN108126062A/en
Application granted granted Critical
Publication of CN108126062B publication Critical patent/CN108126062B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of Chinese medicines, more particularly to a kind of oral Chinese medicine composition for treating depression and its preparation and preparation method.The oral Chinese medicine composition of the treatment depression is made of pharmaceutically acceptable pharmaceutic adjuvant and radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom, wherein radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom, which are adopted, is extracted with water the extraction of the alcohol precipitation method, and Manjusri orchid uses volatile oil component of the extraction by steam distillation relative density below 1.0.The dosage form of the oral Chinese medicine composition is preferably oral liquid.The oral Chinese medicine composition has good therapeutic effect and safety to depression.

Description

A kind of oral Chinese medicine composition for treating depression and its preparation and preparation method
Technical field
The invention belongs to the field of Chinese medicines, and in particular to a kind of oral Chinese medicine composition for treating depression and its preparation and system Preparation Method.
Background technology
Depression is a kind of emotional handicap syndrome, and patient is mainly shown as significantly and lasting depressed, compassion of feeling oneself inferior See world-weary, decreased energy, appetite changes, more or less, decreased attention of sleeping;Lack social interaction desire and explore and be intended to It hopes, introgression even occurs in serious patient.It is not fully understood at present about the pathogenic factor of depression and pathogenesis. It is believed that depression may be the result of physiology, psychology and social factor interaction.Rhythm of life accelerate and work, Study and social pressure increasing may be the external environmental factor for leading to depression.It is reported that Chinese depression illness rate is about 3% ~ 5%, the regional disparity of illness rate is larger.Chinese incidence of depression has increased 10 ~ 20 times in the past 30 years, and still in rising Trend becomes and seriously affects public's health even Neurological disease of patient's personal safety.
Modern medicine mainly adjusts certain relevant neurotransmitters to the treatment of depression using chemicals, to reach control The purpose of depression clinical symptoms processed.The chemicals listed include:Tricyclic drugs, monoamine oxidase inhibit class medicine Object, serotonin reuptake transporter inhibit, norepinephrine reuptake inhibits, and serotonin and norepinephrine reuptake are dual Inhibitor, 5-hydroxytryptamine receptor retarding agent etc., specific drug such as Mirtazapine, Duloxetine, imipramine etc..Said medicine exists Significant psychiatric system side effect is such as had a headache, nausea, is had a sleepless night.
Research about Chinese medicine class antidepressant has been achieved with certain progress.It has now been discovered that radix bupleuri adds keel It is oyster soup, banxia houpu decoction, ganmai dazao decoction, Baihe Dihuang Decoction with additives, Xiao Jianzhong Tang, solution Yu Hehuan soup, Chai Hu Shu Gan San, free and unfettered The Chinese medicine compound prescriptions such as distant scattered, Yueju Wan have depression certain therapeutic effect, and good security(Wang Yan, old a little perfume resist The progress contemporary Chinese Chinese medicines of depressed Chinese medicine compound prescription, 2009,11 (4):6-9.).In the research to single medicinal material In it has been found that Guttiferae hypericum hypericum perforatum, Rubiaceae Morinda plant Morinda officinalis, the black liter of cohosh Fiber crops, Araliaceae herbaceos perennial ginseng are respectively provided with antidepressant effect.But presently, the domestic existing anti-depression Chinese medicament in China Less varieties lack compound preparation product.
Invention content
For the above-mentioned prior art, an object of the present invention is to provide a kind of oral traditional Chinese medicine combination for treating depression Object.To achieve the above object, the technical solution adopted by the present invention is as follows:
A kind of oral Chinese medicine composition for treating depression, by pharmaceutically acceptable pharmaceutic adjuvant and following traditional Chinese medicinal material raw materials It is made:Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom;Wherein radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom use water The extraction of the alcohol precipitation method is extracted, Manjusri orchid uses volatile oil component of the extraction by steam distillation relative density below 1.0.
Preferably, the weight part ratio of the traditional Chinese medicinal material raw materials is:21~35 parts by weight of radix bupleuri, 16~20 parts by weight of Radix Angelicae Sinensis, 16~20 parts by weight of Radix Paeoniae Alba, 7~13 parts by weight of cassia twig, 2~7 parts by weight of Manjusri orchid, 2~6 parts by weight of elm mushroom.
Preferably, the weight part ratio of the traditional Chinese medicinal material raw materials is:33 parts by weight of radix bupleuri, 19 parts by weight of Radix Angelicae Sinensis, 19 weight of Radix Paeoniae Alba Measure part, 12 parts by weight of cassia twig, 6 parts by weight of Manjusri orchid, 5 parts by weight of elm mushroom.
Preferably, the weight part ratio of the traditional Chinese medicinal material raw materials is:30 parts by weight of radix bupleuri, 18 parts by weight of Radix Angelicae Sinensis, 18 weight of Radix Paeoniae Alba Measure part, 11 parts by weight of cassia twig, 3 parts by weight of Manjusri orchid, 4 parts by weight of elm mushroom.
Preferably, the weight part ratio of the traditional Chinese medicinal material raw materials is:27 parts by weight of radix bupleuri, 18 parts by weight of Radix Angelicae Sinensis, 17 weight of Radix Paeoniae Alba Measure part, 9 parts by weight of cassia twig, 5 parts by weight of Manjusri orchid, 4 parts by weight of elm mushroom.
Preferably, the weight part ratio of the traditional Chinese medicinal material raw materials is:25 parts by weight of radix bupleuri, 19 parts by weight of Radix Angelicae Sinensis, 17 weight of Radix Paeoniae Alba Measure part, 10 parts by weight of cassia twig, 6 parts by weight of Manjusri orchid, 4 parts by weight of elm mushroom.
Preferably, the weight part ratio of the traditional Chinese medicinal material raw materials is:22 parts by weight of radix bupleuri, 17 parts by weight of Radix Angelicae Sinensis, 18 weight of Radix Paeoniae Alba Measure part, 8 parts by weight of cassia twig, 3 parts by weight of Manjusri orchid, 3 parts by weight of elm mushroom.
Another aspect provides a kind of traditional Chinese medicine oral liquid for treating depression, by pharmaceutically acceptable medicine It is made of auxiliary material and following traditional Chinese medicinal material raw materials:Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom;Wherein described Chinese medicine The weight part ratio of raw material is:21~35 parts by weight of radix bupleuri, 16~20 parts by weight of Radix Angelicae Sinensis, 16~20 parts by weight of Radix Paeoniae Alba, cassia twig 7~13 Parts by weight, 2~7 parts by weight of Manjusri orchid, 2~6 parts by weight of elm mushroom;Wherein described radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom It adopts and the extraction of the alcohol precipitation method is extracted with water, the Manjusri orchid uses volatilization of the extraction by steam distillation relative density below 1.0 Oily component;The pharmaceutically acceptable pharmaceutic adjuvant includes beta-cyclodextrin and Tween-80.
Another aspect of the invention provides a kind of preparation method of above-mentioned traditional Chinese medicine oral liquid, includes the following steps:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.22~1.25 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, 10 are added in by every gram of fine powder~13 milliliters of water Ratio into fine powder plus water, impregnate 1 hour, extraction by steam distillation, Extracting temperature is 75 DEG C, and extraction time is 8~11 Hour, volatile oil of the separation relative density below 1.0 is spare;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
Preferably, liquid extract relative density is 1.24 in above-mentioned steps A;Every gram of fine powder adds in 12 milliliters of water in step B, carries It is 10 hours to take the time.
It is yet another aspect of the present invention to provide a kind of extract oral tablet for treating depression, by pharmaceutically acceptable Pharmaceutic adjuvant and following traditional Chinese medicinal material raw materials are made:Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom;Wherein described Chinese medicine The weight part ratio of material raw material is:21~35 parts by weight of radix bupleuri, 16~20 parts by weight of Radix Angelicae Sinensis, 16~20 parts by weight of Radix Paeoniae Alba, cassia twig 7~ 13 parts by weight, 2~7 parts by weight of Manjusri orchid, 2~6 parts by weight of elm mushroom;Wherein described radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm are yellow Mushroom, which is adopted, is extracted with water the extraction of the alcohol precipitation method, and the Manjusri orchid uses extraction by steam distillation relative density waving below 1.0 Hair oil component;The auxiliary material of the tablet includes beta-cyclodextrin, starch, microcrystalline cellulose and magnesium stearate, the system of the granule Preparation Method includes the following steps:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, it is fine that starch, crystallite is added in into liquid extract Dimension element mixing wet granulation, crosses 20 mesh sieve series grains, and 60 DEG C of dryings cross 18 mesh sieve whole grain, add in magnesium stearate tabletting.Wherein form sediment Powder, microcrystalline cellulose dosage be respectively 0.4 times and 0.3 times of liquid extract weight, magnesium stearate dosage is dry particl total weight 0.01 times.
Radix bupleuri described in technical solution of the present invention is umbelliferae bupleurum Bupleurum chinense DC. or narrow leaves The dry root of radix bupleuri Bupleurum scorzonerifolium Willd..It is recorded in 2015 editions《People's Republic of China's medicine Allusion quotation》.
Working as described in technical solution of the present invention, is classified as umbelliferae angelica Angelica sinensis (Oliv.) The dry root of Diels.It is recorded in 2015 editions《Pharmacopoeia of People's Republic of China》.
Radix Paeoniae Alba described in technical solution of the present invention is the dry of ranunculaceae plant Radix Paeoniae Alba Paeonia lactiflora Pall. Dry.It is recorded in 2015 editions《Pharmacopoeia of People's Republic of China》.
The drying that cassia twig described in technical solution of the present invention is canella Chinese cassia tree Cinnamomum cassia Presl Spray.It is recorded in 2015 editions《Pharmacopoeia of People's Republic of China》.
Manjusri orchid described in technical solution of the present invention is Amaryllidaceae Crinum herbaceos perennial crinum asiaticum The drying flower of Crinum asiaticum L. var. sinicum.It is recorded in《National Chinese herbal medicine compilation》With《Chinese book on Chinese herbal medicine (Dai medicine is rolled up)》.The medicine is mostly used as medicine with leaf and bulb, rarely seen to be used as medicine with flower.
Elm mushroom described in technical solution of the present invention is Pleurotaceae Pleurotus elm mushroom Pleurotu s The drying fructification of citrinipileatus Sing.
Beta-cyclodextrin described in technical solution of the present invention acts on starch for ring dextrin glucosyl transferase and generates The cyclic oligosaccharide that is combined with α-Isosorbide-5-Nitrae-glycosidic bond of 7 glucose;Tween-80 described in technical solution of the present invention is oil Smooth 20 Sorbitan Oleate of polyoxyethylene formed with ethylene oxide polymerization of sour sorb.Beta-cyclodextrin and Tween-80 are normal With pharmaceutic adjuvant, it is recorded in 2015 editions《Pharmacopoeia of People's Republic of China》.
The present inventor has found that radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig composition compound have certain resist in experimental study Depression effect;Manjusri orchid does not have antidepressant effect, but has synergistic effect, elm to radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound Yellow mushroom then can inhibit the toxic side effect of Manjusri orchid.Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom Six-element medicinal material group There is good antidepressant effect, and good security into compound.
Specific embodiment
The present invention is further explained with reference to embodiment.It should be understood that following embodiment is only used for solving It releases the present invention rather than limits the scope of the invention.
Embodiment 1 treats traditional Chinese medicine oral liquid and its preparation of depression
Preparation method:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
Embodiment 2 treats traditional Chinese medicine oral liquid and its preparation of depression
Preparation method:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
Embodiment 3 treats traditional Chinese medicine oral liquid and its preparation of depression
Preparation method:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
Embodiment 4 treats traditional Chinese medicine oral liquid and its preparation of depression
Preparation method:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
Embodiment 5 treats traditional Chinese medicine oral liquid and its preparation of depression
Preparation method:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
6 depression drug effect of embodiment and safety experiment
First, the foundation of animal model
SPF grades of healthy male SD rats, 180~220g of weight are provided by Beijing dimension tonneau China animal experimental center, raised in black Longjiang university of TCM Experimental Animal Center, during the experiment keep free water and feed, and feeding environment temperature is 23~25 DEG C, Humidity is 50~60%, and adaptability is fed 1 week before experiment.
Rat 72 is taken, receives the chronic mild unpredictability stress stimulation of 35 days by a definite date, including ice water swimming, round the clock Reverse, binding constraint, folder tail, oscillation, fasting and taboo water.Every group of animal gives a kind of stimulation at random daily, and same stimulation is accumulative It uses no more than 5 times.Each stress concrete operation method it is as follows:
(1)Ice water is swum:Rat is put into 20 liters of buckets for filling 4 DEG C of cold water, continues 5 minutes;
(2)It overturns round the clock:Rat is placed in the dark space that black cloth surrounds by daytime, continues 12 hours, rat is placed in by night In the bright space of incandescent lamp irradiation, continue 12 hours;
(3)Binding constraint, rat is placed in 550 milliliters of mineral water bottles, it is prevented to continue 3 hours from freely activity;
(4)Press from both sides tail:It is clamped with bamboo clip away from 1 centimeters of root of the tail portion, rat is made to cry with a whine, continue 2 minutes;
(5)Oscillation:Rat is placed in horizontal oscillator tube, oscillation stops after 2 minutes;
(6)Fasting:Stop supply feed 24 hours;
(7)Prohibit water:Stop supplying water 24 hours.
2nd, the grouping and administration of animal pattern
Rat is randomly divided into 9 groups, every group 8 after modeling.Gavage gives physiological saline, as model after first group of modeling Group.Second to the 6th group is experimental group, and gavage gives the oral liquid of the preparation of embodiment 1,2,3,4,5 respectively.7th to the 9th group For positive controls, gavage gives radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound respectively;Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid Compound or radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom compound oral liquid.Unit dosage form is calculated with radix bupleuri raw medicinal herbs 0.3g/kg, daily gastric infusion 1 time, successive administration 28 days.
Wherein radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, the prescription of cassia twig compound and preparation method are as follows:Radix bupleuri 66g, Radix Angelicae Sinensis 38g, Radix Paeoniae Alba 38g, cassia twig 24g.
Recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water to cook 2 Secondary, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, and the water decoction 2 of the 2nd addition 3 times of weight of medicinal material coarse powder is small When, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, and ethyl alcohol is added in into concentrate to be made The percent by volume of ethyl alcohol is 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains refined Liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be 1.24 liquid extracts;12 grams of beta-cyclodextrins is taken to add in liquid extract, according to The ratio that every 100 milliliters of liquid extracts add in 0.8 gram of Tween-80 adds in Tween-80, stirs evenly, oral liquid is made Body preparation.
Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, the prescription of Manjusri's orchid compound and preparation method are as follows:Radix bupleuri 66g, Radix Angelicae Sinensis 38g, Radix Paeoniae Alba 38g, cassia twig 24g, Manjusri orchid 12g.
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water to cook 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, and the water decoction 2 of the 2nd addition 3 times of weight of medicinal material coarse powder is small When, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, and ethyl alcohol is added in into concentrate to be made The percent by volume of ethyl alcohol is 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains refined Liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.24 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, the ratio of 12 milliliters of water is added in by every gram of fine powder Example is into fine powder plus water, immersion 1 hour, extraction by steam distillation, Extracting temperature are 75 DEG C, and extraction time is 10 hours, point It is spare from volatile oil of the relative density below 1.0;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, oral liquid is made.
Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, the prescription of elm mushroom compound and preparation method are as follows:It is radix bupleuri 66g, Radix Angelicae Sinensis 38g, white Chinese herbaceous peony 38g, cassia twig 24g, elm mushroom 10g.
Recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds Water decocts 2 times, and the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the water of the 2nd addition 3 times of weight of medicinal material coarse powder It decocts 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, added in into concentrate Ethyl alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C are overnight, are filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be 1.24 liquid extracts;12 grams of beta-cyclodextrins is taken to add in stream leaching Cream, the ratio that 0.8 gram of Tween-80 is added according to every 100 milliliters of liquid extracts add in Tween-80, stir evenly, be made Oral liquid.
3rd, observation index
1. safety indexes:Animal defecation and diet drinking-water state are observed in administration process daily, rat heart rate was used every 4 days Measuring instrument(Shanghai Yu Yan scientific instrument Co., Ltd)Measure heart rate under every group of rat rest state, every rat is surveyed in 5 minutes It is 3 times fixed, mean value is taken to represent the heart rate value of this day.
2. curative effect index:
24 hours after the last administration, using the Behavioral feature of spacious field measuring rat.Spacious bottom face is 100 cm x 100 Centimetre, it is 40 centimetres high to be divided into 25 square lattices, and spacious case head cover setting camera is for observing activities in rats.It tested Rat is put into center grid by Cheng Zhong, and observation rat is passed through lined(At least 3 pawls stride into)With it is upright(Two forelimbs are from bottom surface at least 1 cm)Number.Every 5 min of rat minute, rat passes through lined quantity and upright number in 4 min after record. Lined quantity is wherein passed through as horizontal movement score, upright number is as vertical movement score.Every rat measures 1 time, surveys Case being opened with alcohol scrub clean after fixed and measuring next rat again, smell is avoided to interfere.
Data carry out statistical disposition using 17. 0 softwares of SPSS.Comparison among groups use one-way analysis of variance and Post Hoc is examined.P<0. 05 are considered as difference with statistical significance.The spacious field experimental result of each group rat see the table below:
Compared with first group and model group: A:P<0.01;Compared with the 7th group:C:P<0.05, D:P<0.01.
By rat model horizontal movement and vertical movement scores as it can be seen that the second to nine group rat horizontal movement score and Vertical movement score is all remarkably higher than first group(P<0.01), illustrate containing radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound oral administration preparation Be significantly improved to the Behavioral feature of depression rat effect.
Compared with the 7th group i.e. radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound oral liquid preparation administration group, the 9th group i.e. radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, the horizontal movement score of elm mushroom compound oral liquid preparation administration group and vertical movement score are without aobvious It writes and improves, illustrate elm mushroom to radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound without synergistic effect.8th group i.e. radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, Cassia twig, the horizontal movement score of Manjusri's orchid compound oral liquid body preparation administration group and vertical movement score are significantly increased(P< 0.05 or P<0.01), illustrate that Manjusri orchid has synergistic effect to radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound.Second to the 6th group The horizontal movement score and vertical movement score of rat are all remarkably higher than the 7th group(P<0.05 or P<0.01), but with the 8th group of phase Than without significant difference, illustrating the addition of elm mushroom does not influence synergy of the Manjusri orchid to radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig compound Effect.
Since after first administration the 16th day, the 8th group of rat, that is, radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri's orchid compound mouth It taking 7 rats of liquid preparation administration group and the deformed symptom of loose watery stool occurs, there is increased heart rate phenomenon in 8 rats, from The heart rate for starting the 8th group of rat on the 16th is between 347~362 beats/min after first administration, the heart of other each group rats Rate is between 324~341 beats/min, until experiment, which terminates above-mentioned symptom, has no improvement.Other group of rat is showed no above-mentioned disease Shape.Illustrate radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig without above-mentioned toxic effect, the addition of Manjusri orchid may be to lead to rat loose watery stool And the reason of increased heart rate, and the addition of elm mushroom then inhibits the toxic effect of Manjusri orchid.

Claims (10)

1. a kind of oral Chinese medicine composition for treating depression, former by pharmaceutically acceptable pharmaceutic adjuvant and following Chinese medicine Material is made:Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom;Wherein radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom use Water extraction alcohol precipitation method extraction, Manjusri orchid use volatile oil component of the extraction by steam distillation relative density below 1.0.
2. the oral Chinese medicine composition for the treatment of depression according to claim 1, which is characterized in that the traditional Chinese medicinal material raw materials Weight part ratio be:21~35 parts by weight of radix bupleuri, 16~20 parts by weight of Radix Angelicae Sinensis, 16~20 parts by weight of Radix Paeoniae Alba, 7~13 weight of cassia twig Part, 2~7 parts by weight of Manjusri orchid, 2~6 parts by weight of elm mushroom.
3. the oral Chinese medicine composition for the treatment of depression according to claim 2, which is characterized in that the traditional Chinese medicinal material raw materials Weight part ratio be:33 parts by weight of radix bupleuri, 19 parts by weight of Radix Angelicae Sinensis, 19 parts by weight of Radix Paeoniae Alba, 12 parts by weight of cassia twig, 6 weight of Manjusri orchid Measure part, 5 parts by weight of elm mushroom.
4. the oral Chinese medicine composition for the treatment of depression according to claim 2, which is characterized in that the traditional Chinese medicinal material raw materials Weight part ratio be:30 parts by weight of radix bupleuri, 18 parts by weight of Radix Angelicae Sinensis, 18 parts by weight of Radix Paeoniae Alba, 11 parts by weight of cassia twig, 3 weight of Manjusri orchid Measure part, 4 parts by weight of elm mushroom.
5. the oral Chinese medicine composition for the treatment of depression according to claim 2, which is characterized in that the traditional Chinese medicinal material raw materials Weight part ratio be:27 parts by weight of radix bupleuri, 18 parts by weight of Radix Angelicae Sinensis, 17 parts by weight of Radix Paeoniae Alba, 9 parts by weight of cassia twig, 5 weight of Manjusri orchid Part, 4 parts by weight of elm mushroom.
6. the oral Chinese medicine composition for the treatment of depression according to claim 2, which is characterized in that the traditional Chinese medicinal material raw materials Weight part ratio be:25 parts by weight of radix bupleuri, 19 parts by weight of Radix Angelicae Sinensis, 17 parts by weight of Radix Paeoniae Alba, 10 parts by weight of cassia twig, 6 weight of Manjusri orchid Measure part, 4 parts by weight of elm mushroom.
7. the oral Chinese medicine composition for the treatment of depression according to claim 2, which is characterized in that the traditional Chinese medicinal material raw materials Weight part ratio be:22 parts by weight of radix bupleuri, 17 parts by weight of Radix Angelicae Sinensis, 18 parts by weight of Radix Paeoniae Alba, 8 parts by weight of cassia twig, 3 weight of Manjusri orchid Part, 3 parts by weight of elm mushroom.
8. a kind of traditional Chinese medicine oral liquid for treating depression, by pharmaceutically acceptable pharmaceutic adjuvant and following traditional Chinese medicinal material raw materials system Into:Radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, Manjusri orchid, elm mushroom;The weight part ratio of wherein described traditional Chinese medicinal material raw materials is:Radix bupleuri 21 ~35 parts by weight, 16~20 parts by weight of Radix Angelicae Sinensis, 16~20 parts by weight of Radix Paeoniae Alba, 7~13 parts by weight of cassia twig, 2~7 weight of Manjusri orchid Part, 2~6 parts by weight of elm mushroom;Wherein described radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom, which are adopted, is extracted with water the extraction of the alcohol precipitation method, The Manjusri orchid uses volatile oil component of the extraction by steam distillation relative density below 1.0;It is described pharmaceutically to connect The pharmaceutic adjuvant received includes beta-cyclodextrin and Tween-80.
9. the preparation method of the traditional Chinese medicine oral liquid for the treatment of depression according to any one of claims 8, includes the following steps:
A, recipe quantity radix bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, cassia twig, elm mushroom is taken to crushed 50 mesh sieve respectively, medicinal material coarse powder is mixed to obtain, adds water It decocts 2 times, the water of the 1st addition 7 times of weight of medicinal material coarse powder decocts 4 hours, the decocting of the 2nd addition 3 times of weight of medicinal material coarse powder It boils 2 hours, filtering merges decocting liquid, is concentrated into the concentrate that relative density is 1.20, stands cooling, second is added in into concentrate Alcohol makes the percent by volume of ethyl alcohol be 75%, and 4 DEG C overnight, is filtered to remove insoluble matter, collects filtrate decompression distillation removal ethyl alcohol, obtains Refined liquid, by refined liquid be concentrated under reduced pressure for 60 °C when relative density be that 1.22~1.25 liquid extracts are spare;
B, recipe quantity Manjusri orchid is taken to be ground into fine powder, adds in volatile oil extractor, 10~13 milliliters of water are added in by every gram of fine powder Ratio into fine powder plus water, impregnate 1 hour, extraction by steam distillation, Extracting temperature is 75 DEG C, and extraction time is 8~11 Hour, volatile oil of the separation relative density below 1.0 is spare;
C, beta-cyclodextrin is taken using the ratio of 7 grams of beta-cyclodextrins according to every milliliter of volatile oil, the saturation that distilled water is added to be made 50 DEG C Volatile oil obtained by step B is slowly dropped into beta-cyclodextrin saturated aqueous solution under heat-retaining condition and stirred 1 hour by aqueous solution, and freezing is dry It is dry to obtain Benexate Hydrochloride;
D, Benexate Hydrochloride obtained by step C is added in into liquid extract obtained by step A, 0.8 is added according to every 100 milliliters of liquid extracts The ratio of gram Tween-80 adds in Tween-80, stirs evenly, dispenses to obtain the final product.
10. the preparation method of the traditional Chinese medicine oral liquid for the treatment of depression according to claim 9, which is characterized in that the step Liquid extract relative density is 1.24 in rapid A;Every gram of fine powder adds in 12 milliliters of water in the step B, and extraction time is 10 hours.
CN201810196624.3A 2018-03-09 2018-03-09 Oral traditional Chinese medicine composition for treating depression, preparation and preparation method thereof Active CN108126062B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810196624.3A CN108126062B (en) 2018-03-09 2018-03-09 Oral traditional Chinese medicine composition for treating depression, preparation and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810196624.3A CN108126062B (en) 2018-03-09 2018-03-09 Oral traditional Chinese medicine composition for treating depression, preparation and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108126062A true CN108126062A (en) 2018-06-08
CN108126062B CN108126062B (en) 2021-04-23

Family

ID=62431148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810196624.3A Active CN108126062B (en) 2018-03-09 2018-03-09 Oral traditional Chinese medicine composition for treating depression, preparation and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108126062B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104069171A (en) * 2014-07-03 2014-10-01 成都中医药大学 Antidepressant medicine composition as well as preparation method and application thereof
CN105477126A (en) * 2015-12-30 2016-04-13 广东药学院 Traditional Chinese medicine extract composition used for treating depression and preparation method and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104069171A (en) * 2014-07-03 2014-10-01 成都中医药大学 Antidepressant medicine composition as well as preparation method and application thereof
CN105477126A (en) * 2015-12-30 2016-04-13 广东药学院 Traditional Chinese medicine extract composition used for treating depression and preparation method and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
国家中医药管理局《中华本草》编委会: "《中华本草.傣药卷》", 31 December 2005, 上海科学技术出版社 *
张洁: "文殊兰属植物化学成分提取分离及其生物活性", 《哈尔滨商业大学学报(自然科学版)》 *
李越兰等: "柴胡-白芍水煎剂对行为绝望抑郁模型小鼠的影响", 《甘肃中医学院学报》 *
王新志等: "《中风脑病诊疗全书》", 31 March 2017, 中国中医药出版社 *
谢忠礼: "加味四逆散对恶劣心境障碍模型大鼠行为学影响", 《陕西中医学院学报》 *

Also Published As

Publication number Publication date
CN108126062B (en) 2021-04-23

Similar Documents

Publication Publication Date Title
WO2012027882A1 (en) Pharmaceutical composition for treating insomnia and preparation method thereof
CN101711810B (en) Preparation used for improving sleep and enhancing immunity
CN102397372A (en) Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome
CN106309645B (en) A pharmaceutical composition with antidepressant effect
CN101396542B (en) Traditional Chinese medicine formulation for treating gastrosis and preparation method thereof
CN104000944B (en) A kind of health products or pharmaceutical composition and its production and use with warming kidney to invigorate yang
CN102293936A (en) Medicinal composition or health food composition for protecting gastric mucosa, and preparation method thereof
CN103705860B (en) A kind of Chinese medicine composition for the treatment of infant jaundice and preparation method thereof
CN100336528C (en) Chinese medicinal preparation for treating high blood pressure and high blood fat
CN102552806A (en) Fat-burning dredging particles and preparation method thereof
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN102641357B (en) Medicament for treating hypertension and preparation method thereof
CN104288514A (en) Traditional Chinese medicine for treating hyperthyroidism
CN101461925B (en) Medicament composition for treating hepatopathy and preparation method thereof
CN100542581C (en) A kind of medicine for the treatment of chronic migraine and general headache
CN108186821B (en) Traditional Chinese medicine composition for treating nervous headache and preparation method and application thereof
CN108126062A (en) A kind of oral Chinese medicine composition for treating depression and its preparation and preparation method
CN1181880C (en) Compound macrostem onion preparation for curing chronic obstructive lung disease and its preparing method
CN105727089A (en) Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome
CN101732688B (en) Amlodipine-containing medicament
CN1081042C (en) Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof
CN100486621C (en) Chinese medicinal composition for treating hemilateral headache and its preparation method
CN104223062B (en) Root bark of Chinese wolf-berry health care oral liquid of a kind of reducing pressure and sugar and preparation method thereof
CN101708326B (en) Medicine containing nifedipine
CN108096346B (en) Qianluoye cherry pit composition, preparation method thereof and application thereof in preparation of gastrointestinal motility promoting medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant